Canopy Growth upgraded by Canaccord Genuity
$CGC
Medicinal Chemicals and Botanical Products
Health Care
Canaccord Genuity upgraded Canopy Growth from Sell to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/4/2023 | Underperform → Mkt Perform | Bernstein | |
| 11/2/2022 | $1.50 | Underperform | Bernstein |
| 10/26/2022 | Sell → Hold | Canaccord Genuity | |
| 6/8/2022 | Market Perform → Underperform | BMO Capital Markets | |
| 3/22/2022 | Equal Weight → Underweight | Barclays | |
| 3/1/2022 | $14.00 → $9.00 | Equal-Weight | Barclays |
| 2/18/2022 | $9.60 → $11.00 | Neutral | Cantor Fitzgerald |
| 12/22/2021 | Neutral → Underperform | BofA Securities |
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and reconvened on, October 10, 2025 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 7, 2025 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of t
Kelowna site to produce craft cannabis under the DOJA brand exclusively for Spectrum Therapeutics patients, advancing Canopy Growth's commitment to Canada's medical market Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that its DOJA facility in Kelowna, British Columbia is now operating exclusively as a medical cultivation site supporting the Company's Spectrum Therapeutics portfolio in Canada. The Kelowna facility will cultivate small-batch, BC-grown craft cannabis under the DOJA brand, available only to registered Spectrum Therapeutics
DALLAS, Oct. 7, 2025 /PRNewswire/ -- JP Brand Advisors ("JPBA"), the leading outsourced sales and strategy partner for beverage alcohol and emerging functional beverage brands, and Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced a strategic partnership to expand the distribution of Wana Wellness, LLC ("Wana")'s hemp-based beverages and gummies in the United States. The partnership underscores JPBA's expanding focus on hemp-based functional beverages, a category generating significant attentio
3 - Canopy Growth Corp (0001737927) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
Bernstein upgraded Canopy Growth from Underperform to Mkt Perform
Bernstein initiated coverage of Canopy Growth with a rating of Underperform and set a new price target of $1.50
Canaccord Genuity upgraded Canopy Growth from Sell to Hold
8-K - Canopy Growth Corp (0001737927) (Filer)
DEFA14A - Canopy Growth Corp (0001737927) (Filer)
DEFA14A - Canopy Growth Corp (0001737927) (Filer)
4 - Canopy Growth Corp (0001737927) (Issuer)
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and reconvened on, October 10, 2025 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 7, 2025 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of t
Appointment finalizes CFO transition and reinforces Canopy Growth's focus on operational discipline, financial stability, and long-term value creation Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced that Tom Stewart has been appointed Chief Financial Officer, effective immediately. Mr. Stewart's appointment supports the continued execution of Canopy Growth's fiscal year 2026 strategy, which is marked by structural efficiency, operational and commercial focus, and disciplined capital allocation and cost management. With significant progres
BOULDER, Colo., Aug. 27, 2025 /PRNewswire/ -- Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the U.S. cannabis market, today announced the appointment of Eric Ruhle as Vice President of Brand Sales, overseeing sales strategy across the full Canopy USA portfolio. With more than 11 years of experience in the regulated cannabis industry, Ruhle brings deep expertise in building and leading high-performing sales organizations. Most recently, he served as Senior Regional Sales Manager at Kiva Sales & Services, where he navigated the highl
Canada adult-use cannabis Q1 FY2026 net revenue increased 43% year-over-year, benefiting from increased distribution and strong consumer demand for new products, including Claybourne infused pre-roll joints Company has achieved $17MM of planned $20MM annualized savings target since March 1, 2025; SG&A expenses down 21% year-over-year in Q1 FY2026 compared to Q1 FY2025 Supply chain improvements in international markets expected to increase cannabis supply and consistency in margin accretive European markets in the second half of FY2026 Company expects to launch a new Storz & Bickel vaporizer during the second half of the calendar year Canopy Growth Corporation ("Canopy Growth" or th
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the first quarter fiscal year 2026 ended June 30, 2025 before financial markets open on August 8, 2025. Following the release of its first quarter fiscal year 2026 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Tom Stewart, Interim CFO on August 8, 2025 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=8135284A-F8CD-45B7-A384-634DE6714986 Replay Information A replay will be accessible by webcast until 11:59 PM ET on November 6, 2025 at:
Canada cannabis revenue increased 4% in Q4 FY2025 year-over-year, led by 13% growth in Canada medical cannabis Reduced total debt by $293 million or 49% during FY2025 Refined strategy, focus and organizational structure expected to accelerate growth in global medical cannabis and improve commercial execution in Canada adult-use cannabis Additional cost reduction initiatives identified and initiated in Q4 FY2025 are expected to deliver at least $20 million in annualized savings over the next 12-18 months Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced its financial results for the fourth quarter ended March 31, 2025 ("Q4 FY2025") a
SC 13D/A - Canopy Growth Corp (0001737927) (Subject)
SC 13D/A - Canopy Growth Corp (0001737927) (Subject)
SC 13D/A - Canopy Growth Corp (0001737927) (Subject)